I. Takahashi et al., MECHANISMS FOR MUCOSAL IMMUNOGENICITY AND ADJUVANCY OF ESCHERICHIA-COLI LABILE ENTEROTOXIN, The Journal of infectious diseases, 173(3), 1996, pp. 627-635
Escherichia coli labile toxin (LT) was assessed as mucosal immunogen a
nd as adjuvant for tetanus toroid (TT) in mice, After oral administrat
ion of LT, C57BL/6 (H-2(b)) and BALB/c (H-2(d)) mice were high mucosal
and serum antibody responders, while C3H/HeN (H-2(k)) mice were low r
esponders. High responders exhibited mainly serum Ige (including IgG1,
IgG2a, and IgG2b), as well as IgM and IgA, while mucosal responses we
re IgA. Analysis of LT-B-specific CD4(+) T helper (Th) cells from Peye
r's patches (PP) or from spleen revealed a mixed Th1 (interferon-gamma
) and Th2 (interleukin-4 and -5) cell pattern, Oral LT given with TT i
nduced TT-specific response patterns identical to LT-B, Analysis of mR
NA from TT-specific PP CD4(+) Th cells also revealed a mixed Th1- and
Th2-type response. Thus, antibody response profiles induced by LT are
regulated by both CD4(+) Th1 and Th2 cell types.